Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Phytochem Anal ; 26(1): 34-9, 2015.
Article in English | MEDLINE | ID: mdl-25130411

ABSTRACT

INTRODUCTION: In our continued efforts to contribute to the general knowledge on the chemical diversity of orchids, we have decided to focus our investigations on the Aeridinae subtribe. Following our previous phytochemical study of Vanda coerulea, which has led to the identification of phenanthrene derivatives, a closely related species, Aerides rosea Lodd. ex Lindl. & Paxton, was chosen for investigation. OBJECTIVE: To identify new secondary metabolites, and to avoid isolation of those already known, by means of the combined systems HPLC-DAD(diode-array detector) with high-resolution tandem mass spectrometry (HRMS/MS) and HPLC-DAD-MS-SPE(solid-phase extraction)-UV-NMR. METHODS: A dereplication strategy was developed using a HPLC-DAD-HRMS/MS targeted method and applied to fractions from A. rosea stem extract. Characterisation of unknown minor compounds was then performed using the combined HPLC-DAD-MS-SPE-UV-NMR system. RESULTS: The dereplication method allowed the characterisation of four compounds (gigantol, imbricatin, methoxycoelonin and coelonin), previously isolated from Vanda coerulea stem extract. The analyses of two fractions permitted the identification of five additional minor constituents including one phenanthropyran, two phenanthrene and two dihydrophenanthrene derivatives. The full set of NMR data of each compound was obtained from microgram quantities. CONCLUSION: Nine secondary metabolites were characterised in A. rosea stems, utilising HPLC systems combined with high-resolution analytical systems. Two of them are newly described phenanthrene derivatives: aerosanthrene (5-methoxyphenanthrene-2,3,7-triol) and aerosin (3-methoxy-9,10-dihydro-2,5,7-phenanthrenetriol).


Subject(s)
Orchidaceae/chemistry , Phenanthrenes/isolation & purification , Spectrometry, Mass, Electrospray Ionization/methods , Chromatography, High Pressure Liquid , Magnetic Resonance Spectroscopy , Molecular Structure , Phenanthrenes/chemistry , Plant Stems/chemistry , Solid Phase Extraction , Tandem Mass Spectrometry
2.
Pharm Res ; 30(5): 1362-79, 2013 May.
Article in English | MEDLINE | ID: mdl-23371513

ABSTRACT

PURPOSE: Biolabile cationic lipids were developed for efficient intracellular delivery of DNA and siRNA. METHODS: The compounds have been designed starting from the membrane lipid DOPC in a way they may loose their cationic charge when exposed to an acidic and/or enzymatic stimulus, such as those met during the journey of a lipoplex in biological media. RESULTS: They demonstrated remarkable efficiency to deliver DNA in various cell lines (BHK-21, Calu-3, NCI-H292, and A549), with no significant cytotoxicity. Furthermore, two of the compounds (carbonate-based DOPC derivatives) revealed able to deliver small interfering RNA in U87Luc and A549Luc cancer cells and to mediate a selective 70-80% knockdown of the stably transfected luciferase gene. CONCLUSIONS: The results show that the described bioresponsive cationic lipids have high DNA and siARN delivery activity which is encouraging in view of delivering a therapeutic nucleic acid to pulmonary tissues in vivo.


Subject(s)
DNA/administration & dosage , Liposomes/chemistry , Phosphatidylcholines/chemistry , RNA, Small Interfering/administration & dosage , Surface-Active Agents/chemistry , Transfection , Animals , Cations/chemistry , Cell Line , Cell Line, Tumor , DNA/genetics , Humans , Luciferases/genetics , Plasmids/administration & dosage , Plasmids/genetics , RNA Interference , RNA, Small Interfering/genetics
3.
Chemistry ; 19(7): 2344-55, 2013 Feb 11.
Article in English | MEDLINE | ID: mdl-23296638

ABSTRACT

One of the potential benefits of drug delivery systems in medicine is the creation of nanoparticle-based vectors that deliver a therapeutic cargo in sufficient quantity to a target site to enable a selective effect, width of the therapeutic window depending on the toxicity of the vector and the cargo. In this work, we intended to improve the siRNA delivery efficiency of a new kind of nucleic acid carrier, which is the result of the conjugation of the membrane phospholipid 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) to the membrane-active species Triton X-100 (TX100). We hypothesized that by improving the biodegradability the cytotoxicity of the conjugate might by reduced, whereas its original transfection potential would be tentatively preserved. DOPC was conjugated to Triton X-100 through spacers displaying various resistance to chemical hydrolysis and enzyme degradation. The results obtained through in vitro siRNA delivery experiments showed that the initial phosphoester bond can be replaced with a phospho(alkyl)enecarbonate group with no loss in the transfection activity, whereas the associated cytotoxicity was significantly decreased, as assessed by metabolic activity and membrane integrity measurements. The toxicity of the conjugates incorporating a phospho(alkyl)enesuccinnate moiety proved even lower but was clearly balanced with a reduction of the siRNA delivery efficiency. Hydrolytic stability and intracellular degradation of the conjugates were investigated by NMR spectroscopy and mass spectrometry. A general trend was that the more readily degraded conjugates were those with the lower toxicity. Otherwise, the phospho(alkyl)enecarbonate conjugates revealed some hemolytic activity, whereas the parent phosphoester did not. The reason why these conjugates behave differently with respect to hemolysis might be a consequence of unusual fusogenic properties and probably reflects the difference in the stability of the conjugates in the intracellular environment.


Subject(s)
Detergents/chemistry , Detergents/pharmacology , Glycerylphosphorylcholine/analogs & derivatives , Nanoparticles/chemistry , Nucleic Acids/chemistry , Phospholipids/pharmacology , Phosphorylcholine/chemistry , Phosphorylcholine/pharmacology , RNA, Small Interfering/chemistry , RNA, Small Interfering/pharmacology , Cell Line, Tumor , Drug Delivery Systems , Glycerylphosphorylcholine/chemistry , Humans , Magnetic Resonance Spectroscopy , Mass Spectrometry , Phosphatidylcholines , RNA, Small Interfering/metabolism , Transfection
4.
FEBS Lett ; 586(1): 96-101, 2012 Jan 02.
Article in English | MEDLINE | ID: mdl-22172280

ABSTRACT

Pyoverdine I (PVDI) is the major siderophore produced by Pseudomonas aeruginosa to import iron. Biosynthesis of this chelator involves non-ribosomal peptide synthetases and other enzymes. PvdQ is a periplasmic enzyme from the NTN hydrolase family and is involved in the final steps of PVDI biosynthesis. A pvdQ mutant produces two non-fluorescent PVDI precursors with a higher molecular mass than PVDI. In the present study, we describe the use of mass spectrometry to determine the structure of these PVDI precursors and show that they both contain a unformed chromophore like ferribactin, and either a myristic or myristoleic chain that must be removed before PVDI is secreted into the extracellular medium.


Subject(s)
Fatty Acids, Monounsaturated/chemistry , Myristic Acid/chemistry , Oligopeptides/biosynthesis , Pseudomonas aeruginosa/metabolism , Siderophores/biosynthesis , Fluorescence , Mass Spectrometry , Molecular Structure , Molecular Weight , Mutation , Oligopeptides/chemistry , Peptide Synthases/genetics , Peptide Synthases/metabolism
5.
Anal Biochem ; 380(2): 202-10, 2008 Sep 15.
Article in English | MEDLINE | ID: mdl-18565321

ABSTRACT

The applicability of gas chromatography-combustion-isotope ratio mass spectrometry (GC-C-IRMS) for the quantification of 13C enrichment of proteinogenic amino acids in metabolic tracer experiments was evaluated. Measurement of the 13C enrichment of proteinogenic amino acids from cell hydrolyzates of Corynebacterium glutamicum growing on different mixtures containing between 0.5 and 10% [1-13C]glucose shows the significance of kinetic isotope effects in metabolic flux studies at low degree of labeling. We developed a method to calculate the 13C enrichment. The approach to correct for these effects in metabolic flux studies using delta13C measurement by GC-C-IRMS uses two parallel experiments applying substrate with natural abundance and 13C-enriched tracer substrate, respectively. The fractional enrichment obtained in natural substrate is subtracted from that of the enriched one. Tracer studies with C. glutamicum resulted in a statistically identical relative fractional enrichment of 13C in proteinogenic amino acids over the whole range of applied concentrations of [1-13C]glucose. The current findings indicate a great potential of GC-C-IRMS for labeling quantification in 13C metabolic flux analysis with low labeling degree of tracer substrate directly in larger scale bioreactors.


Subject(s)
Amino Acids/analysis , Carbon Isotopes/analysis , Corynebacterium glutamicum/metabolism , Gas Chromatography-Mass Spectrometry/methods , Isotope Labeling/methods , Amino Acids/metabolism , Carbon Isotopes/metabolism , Corynebacterium glutamicum/chemistry , Corynebacterium glutamicum/growth & development , Glucose/analysis , Glucose/metabolism , Glucose/pharmacokinetics , Kinetics
SELECTION OF CITATIONS
SEARCH DETAIL
...